Výsledky vyhľadávania - "Depressive Disorder, Major drug therapy"

The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression

Autori: Goodwin, Guy M. Aaronson, Scott T. Alvarez, Oscar a ďalší

Zdroj: Goodwin, G M, Aaronson, S T, Alvarez, O, Carhart-Harris, R, Chai-Rees, J, Croal, M, DeBattista, C, Dunlop, B W, Feifel, D, Hellerstein, D J, Husain, M I, Kelly, J R, Kirlic, N, Licht, R W, Marwood, L, Meyer, T D, Mistry, S, Nowakowska, A, Páleníček, T, Repantis, D, Schoevers, R A, Simmons, H, Somers, M, Teoh, E, Tsai, J, Wahba, M, Williams, S, Young, A H, Young, M B, Zisook, S & Malievskaia, E 2025, 'The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression', Journal of Affective Disorders, vol. 372, pp. 523-532. https://doi.org/10.1016/j.jad.2024.12.061
Goodwin, G M, Aaronson, S T, Alvarez, O, Carhart-Harris, R, Chai-Rees, J, Croal, M, DeBattista, C, Dunlop, B W, Feifel, D, Hellerstein, D J, Husain, M I, Kelly, J R, Kirlic, N, Licht, R W, Marwood, L, Meyer, T D, Mistry, S, Nowakowska, A, Páleníček, T, Repantis, D, Schoevers, R A, Simmons, H, Somers, M, Teoh, E, Tsai, J, Wahba, M, Williams, S, Young, A H, Young, M B, Zisook, S & Malievskaia, E 2025, 'The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression', Journal of affective disorders, vol. 372, pp. 523-532. https://doi.org/10.1016/j.jad.2024.12.061

Predmety: Male, Adult, Depressive Disorder, Treatment-Resistant, Double-Blind Method, Psilocybin/pharmacology, Surveys and Questionnaires, Humans, Psychiatric Status Rating Scales, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant/drug therapy, Dose-Response Relationship, Drug, Depressive Disorder, Major/drug therapy, Hallucinogens/administration & dosage, Middle Aged, Dose-response, Psilocybin, Clinical Psychology, Psychiatry and Mental health, Randomized-control trial, Psychedelic experience, Treatment Outcome, Hallucinogens, Psychedelic, Female, Treatment-resistant depression

Popis súboru: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39706482
https://dspace.library.uu.nl/handle/1874/459944
https://kclpure.kcl.ac.uk/portal/en/publications/680b0cb8-8e51-4092-a171-0632b93c84a0

Phosphatidic acid is involved in regulation of autophagy in neurons in vitro and in vivo

Autori: Schiller, Maximilian Wilson, Gregory C. Keitsch, Simone a ďalší

Zdroj: Pflugers Arch

Predmety: Neurons, Male, Depressive Disorder, Major, Medizin, Phosphatidic Acids, PC12 Cells, Hippocampus, Rats, Mice, Inbred C57BL, Mice, PC12 Cells [MeSH], Mice, Inbred C57BL [MeSH], Depressive Disorder, Major/drug therapy [MeSH], Depressive Disorder, Major/metabolism [MeSH], Phosphatidic acid, Ceramide, Neurons/drug effects [MeSH], Original Article, Phosphatidic Acids/pharmacology [MeSH], Male [MeSH], Stress, Psychological/metabolism [MeSH], Hippocampus/metabolism [MeSH], Phosphatidic Acids/metabolism [MeSH], Major depression, Autophagy, Neurons/metabolism [MeSH], Rats [MeSH], Animals [MeSH], Autophagy/drug effects [MeSH], Mice [MeSH], Gangliosides, Autophagy/physiology [MeSH], Hippocampus/drug effects [MeSH], Corticosterone/blood [MeSH], Corticosterone/pharmacology [MeSH], Animals, Corticosterone, Stress, Psychological

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39375214
https://repository.publisso.de/resource/frl:6512490

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

Autori: Paul Glue Colleen Loo Johnson Fam a ďalší

Zdroj: Nat Med
Glue, P, Loo, C, Fam, J, Lane, H-Y & Young, A H & Surman, P 2024, ' Extended-release ketamine tablets for treatment-resistant depression : a randomized placebo-controlled phase 2 trial ', Nature Medicine, vol. 30, no. 7, pp. 2004-2009 . https://doi.org/10.1038/s41591-024-03063-x

Predmety: Male, Adult, Clinical Trials and Supportive Activities, 32 Biomedical and Clinical Sciences, anzsrc-for: 3214 Pharmacology and Pharmaceutical Sciences, Article, Depressive Disorder, Treatment-Resistant, anzsrc-for: 32 Biomedical and Clinical Sciences, Double-Blind Method, Clinical Research, Treatment-Resistant/drug therapy, Humans, Antidepressive Agents/administration & dosage, 3202 Clinical Sciences, Aged, Depressive Disorder, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant/drug therapy, Depression, anzsrc-for: 42 Health sciences, Depressive Disorder, Major/drug therapy, Treatment-Resistant, Major, Middle Aged, Serious Mental Illness, Mental Illness, 3214 Pharmacology and Pharmaceutical Sciences, BEDROC study investigators, Antidepressive Agents, Brain Disorders, 3. Good health, Mental Health, Treatment Outcome, anzsrc-for: 11 Medical and Health Sciences, 6.1 Pharmaceuticals, Delayed-Action Preparations, Major/drug therapy, Women's Health, anzsrc-for: 3202 Clinical Sciences, Ketamine, Female, Patient Safety, Ketamine/administration & dosage, Tablets

Popis súboru: application/vnd.openxmlformats-officedocument.wordprocessingml.document; application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38914860
https://kclpure.kcl.ac.uk/ws/files/278404295/E-R_Ketamine_Tablets_for_TRD_clean_copy_format_7-5-24.docx

The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis: a systematic review with meta-analysis and trial sequential analysis

Autori: Kamp, Caroline Barkholt Petersen, Johanne Juul Faltermeier, Pascal a ďalší

Zdroj: BMC Psychiatry
BMC Psychiatry, Vol 25, Iss 1, Pp 1-11 (2025)

Predmety: Adult, Adverse event, Attempted/statistics & numerical data, RC435-571, Suicide, Attempted, Antidepressant, Mirtazapine, 616.8: Neurologie und Krankheiten des Nervensystems, Major depressive disorder, Antidepressive Agents, Tricyclic, Weight Gain, 615: Pharmakologie und Therapeutik, Humans, Randomized Controlled Trials as Topic, Psychiatry, Depressive Disorder, Depressive Disorder, Major, Systematic Review, Suicide, Attempted/statistics, Mirtazapine/adverse effects [MeSH], Adult [MeSH], Humans [MeSH], Antidepressive Agents, Tricyclic/adverse effects [MeSH], Depressive Disorder, Major/drug therapy [MeSH], Systematic review, Randomized Controlled Trials as Topic [MeSH], Adverse events, Suicide/statistics, Mirtazapine/therapeutic use [MeSH], Antidepressive Agents, Tricyclic/therapeutic use [MeSH], Antidepressants, Suicide/statistics & numerical data, Antidepressive Agents, Suicide, Major/drug therapy, Tricyclic/adverse effects, Mirtazapine/therapeutic use

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39844067
https://doaj.org/article/7060e735e1064c4e952950a32528c975
https://repository.publisso.de/resource/frl:6524722

Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis

Autori: Li, Danyang Pain, Oliver Chiara, Fabbri a ďalší

Zdroj: Transl Psychiatry
Translational Psychiatry, Vol 14, Iss 1, Pp 1-8 (2024)
Li, D, Pain, O, Fabbri, C, Wong, E, Lo, C, Ripke, S, Cattaneo, A, Souery, D, Dernovsek, M Z, Henigsberg, N, Hauser, J, Lewis, G, Mors, O, Perroud, N, Rietschel, M, Uher, R, Maier, W, Baune, B T, Biernacka, J M, Bondolfi, G, Domschke, K, Kato, M, Liu, Y-L, Serretti, A, Tsai, S J, Weinshilboum, R, M. McIntosh, A & Lewis, C 2024, 'Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation : a meta-analysis', Translational psychiatry, vol. 14, 296 . https://doi.org/10.1038/s41398-024-02981-1
Translational Psychiatry, 14(1):296
the GSRD Consortium, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium & Christensen, J H 2024, 'Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation : a meta-analysis', Translational Psychiatry, vol. 14, no. 1, 296. https://doi.org/10.1038/s41398-024-02981-1

Predmety: Male, Genotype, Neurosciences. Biological psychiatry. Neuropsychiatry, Antidepressive Agents/therapeutic use, Asian People/genetics, Article, White People, Cytochrome P-450 CYP2D6 / genetics, Depressive Disorder, Major / drug therapy, White People / genetics, Asian People / genetics, Asian People, Depressive Disorder, Major / genetics, Humans, Antidepressive Agents / therapeutic use, Depressive Disorder, Major, Depressive Disorder, Major/drug therapy, Depressive Disorder, Major / metabolism, Antidepressive Agents, 3. Good health, Cytochrome P-450 CYP2C19, Cytochrome P-450 CYP2C19 / genetics, Phenotype, Treatment Outcome, Cytochrome P-450 CYP2D6 / metabolism, Cytochrome P-450 CYP2D6, Female [MeSH], Asian People/genetics [MeSH], 45/61, Cytochrome P-450 CYP2D6/genetics [MeSH], Humans [MeSH], Depressive Disorder, Major/drug therapy [MeSH], Depressive Disorder, Major/metabolism [MeSH], Treatment Outcome [MeSH], Depressive Disorder, Major/genetics [MeSH], 692/53/2423, Cytochrome P-450 CYP2D6/metabolism [MeSH], Cytochrome P-450 CYP2C19/genetics [MeSH], 692/699/476/1414, Male [MeSH], White People/genetics [MeSH], Genotype [MeSH], Phenotype [MeSH], Antidepressive Agents/therapeutic use [MeSH], article, 616.89, NA, Female, Cytochrome P-450 CYP2C19/genetics, Cytochrome P-450 CYP2D6/genetics, White People/genetics, RC321-571

Popis súboru: application/pdf; pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39025838
https://doaj.org/article/78b6105acfec40b1aa485bf11a65c749
https://archive-ouverte.unige.ch/unige:180387
https://doi.org/10.1038/s41398-024-02981-1
https://kclpure.kcl.ac.uk/portal/en/publications/fd538320-0be9-41f2-a650-ec5d44224471
https://repository.publisso.de/resource/frl:6507972
https://urn.nsk.hr/urn:nbn:hr:105:412499
https://doi.org/10.1038/s41398-024-02981-1
https://pure.au.dk/portal/en/publications/e1ef9a45-0d42-4216-9d90-2a79d210c3f9
https://doi.org/10.1038/s41398-024-02981-1
http://www.scopus.com/inward/record.url?scp=85199127429&partnerID=8YFLogxK

Regaining control over alcohol intake but not abstinence on disulfiram medication, as a harm reduction approach: 2 case reports

Autori: Max Schallenberg Maximilian Pilhatsch Johannes Petzold a ďalší

Zdroj: Addict Sci Clin Pract
Addiction Science & Clinical Practice, Vol 19, Iss 1, Pp 1-5 (2024)

Predmety: Adult, Male, Alcohol dependence treatment, Harm reduction, Medicine (General), Depressive Disorder, Major, Disulfiram, Female [MeSH], Adult [MeSH], Humans [MeSH], Depressive Disorder, Major/drug therapy [MeSH], Middle Aged [MeSH], Alcohol Abstinence [MeSH], Disulfiram/therapeutic use [MeSH], Reduced drinking, Male [MeSH], Alcohol Drinking [MeSH], Alcohol use disorder, Alcohol Deterrents/therapeutic use [MeSH], Alcoholism/drug therapy [MeSH], Case Report, Harm Reduction [MeSH], Alcohol Drinking, Alcohol Abstinence, Middle Aged, Alcoholism, 03 medical and health sciences, R5-920, 0302 clinical medicine, Social pathology. Social and public welfare. Criminology, Harm Reduction, Humans, Female, HV1-9960, Alcohol Deterrents

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39623440
https://doaj.org/article/1597238597ff48d292c447e2a96c1a56
https://repository.publisso.de/resource/frl:6495551

Accelerated Repetitive Transcranial Magnetic Stimulation to Treat Major Depression: The Past, Present, and Future: The Past, Present, and Future

Autori: Chen, Leo Klooster, Deborah C W Tik, Martin a ďalší

Prispievatelia: Chen, Leo Klooster, Deborah C W Tik, Martin a ďalší

Zdroj: Harvard Review of Psychiatry. 31:142-161

Predmety: Depressive Disorder, Major, major depressive disorder, Depressive Disorder, Major/drug therapy, Depression, brain stimulation, Depression/therapy, Antidepressive Agents/therapeutic use, Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation/adverse effects, Antidepressive Agents, 3. Good health, Treatment Outcome, depression, transcranial magnetic stimulation, accelerated transcranial magnetic stimulation, 302065 Psychiatrie, Humans, repetitive transcranial stimulation, 302065 Clinical psychiatry

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37171474
https://ucrisportal.univie.ac.at/de/publications/5e7d6c2e-5567-4256-81c9-dce443a34252
https://doi.org/10.1097/HRP.0000000000000364
https://biblio.vub.ac.be/vubir/(a295a48f-1849-48f1-9ab2-3051b5e21eb6).html

The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression

Autori: Matea Nikolac Perkovic Martin Gredicak Marina Sagud a ďalší

Zdroj: Expert Review of Molecular Diagnostics. 23:283-296

Predmety: Antidepressive Agents / therapeutic use, Depressive Disorder, Major / diagnosis, Depressive Disorder, Major, Genotype, Depression, Brain-Derived Neurotrophic Factor / genetics, Brain-Derived Neurotrophic Factor, Depression / etiology, Polymorphism, Single Nucleotide, Depression / drug therapy, Antidepressive Agents, 3. Good health, Depressive Disorder, Major / drug therapy, BDNF, BDNF Val66Met, antidepressants, depression, treatment response, Depressive Disorder, Major / genetics, Humans, Brain-Derived Neurotrophic Factor / therapeutic use, Depression / diagnosis

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37038358
https://urn.nsk.hr/urn:nbn:hr:105:267765
https://doi.org/10.1080/14737159.2023.2200937

The association between maximal muscle strength, disease severity and psychopharmacotherapy among young to middle-aged inpatients with affective disorders – a prospective pilot study

Autori: Hannah Ramming Linda Theuerkauf Olaf Hoos a ďalší

Zdroj: BMC Psychiatry
BMC Psychiatry, Vol 24, Iss 1, Pp 1-15 (2024)

Predmety: Male, Adult, Bipolar Disorder, Adolescent, Bipolar disorder, Young, RC435-571, Pilot Projects, Severity of Illness Index, Affective disorder, Young Adult, 03 medical and health sciences, Depressive Disorder, Major/drug therapy [MeSH], Bipolar Disorder/drug therapy [MeSH], Muscle strength, Psychotic Disorders/drug therapy [MeSH], Depressive Disorder, Major/physiopathology [MeSH], Depression, Muscle Strength/drug effects [MeSH], Male [MeSH], Bipolar Disorder/physiopathology [MeSH], Inpatients [MeSH], Adolescent [MeSH], Female [MeSH], Muscle Strength/physiology [MeSH], Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Severity of Illness Index [MeSH], Middle Aged [MeSH], Research, Physical activity, Pilot Projects [MeSH], Young Adult [MeSH], Psychotic Disorders/physiopathology [MeSH], Psychopharmacotherapy, 0302 clinical medicine, Humans, Muscle Strength, Prospective Studies, Psychiatry, Inpatients, Depressive Disorder, Major, Middle Aged, 3. Good health, Psychotic Disorders, Female

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38811916
https://doaj.org/article/05fca6f84cd649a2a22e5f7945a1c0c4
https://repository.publisso.de/resource/frl:6490580

Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients—a randomized rater-blinded trial

Autori: Hannah Benedictine Maier Alexandra Neyazi Gabriel L. Bundies a ďalší

Zdroj: Trials
Trials, Vol 25, Iss 1, Pp 1-12 (2024)

Predmety: Medicine (General), Depressive Disorder, Major, Brain-Derived Neurotrophic Factor, Biomarker, Major depressive disorder, 16. Peace & justice, Methylation, Antidepressive Agents, 3. Good health, Study Protocol, 03 medical and health sciences, R5-920, BDNF, 0302 clinical medicine, Antidepressive Agents/adverse effects [MeSH], Methylation [MeSH], RCT, Humans [MeSH], Prospective Studies [MeSH], Depressive Disorder, Major/drug therapy [MeSH], Depressive Disorder, Major/genetics [MeSH], Depressive Disorder, Major/diagnosis [MeSH], Brain-Derived Neurotrophic Factor/genetics [MeSH], Biomarkers [MeSH], Selective Serotonin Reuptake Inhibitors [MeSH], Humans, Prospective Studies, Selective Serotonin Reuptake Inhibitors, Biomarkers

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38594753
https://doaj.org/article/55ea2c6790ba48b2a005ed3270692acc
https://repository.publisso.de/resource/frl:6491644

Adjunctive home-based transcranial direct current stimulation treatment for major depression with real-time remote supervision: An open-label, single-arm feasibility study with long term outcomes

Autori: Rachel D. Woodham Rachael M. Rimmer Allan H. Young a ďalší

Zdroj: Woodham, R D, Rimmer, R M, Young, A H & Fu, C H Y 2022, 'Adjunctive home-based transcranial direct current stimulation treatment for major depression with real-time remote supervision : An open-label, single-arm feasibility study with long term outcomes', Journal of psychiatric research, vol. 153, pp. 197-205. https://doi.org/10.1016/j.jpsychires.2022.07.026

Predmety: Adult, Depressive Disorder, Major, Depressive Disorder, Major/drug therapy, Depression, Depression/therapy, Middle Aged, Antidepressive Agents/therapeutic use, Transcranial Direct Current Stimulation, 16. Peace & justice, Antidepressive Agents, 3. Good health, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Feasibility Studies, Humans, Female, Transcranial Direct Current Stimulation/methods

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35839661
https://kclpure.kcl.ac.uk/portal/en/publications/3749e06f-368d-4b5b-9a08-cf39b543a1a0

Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis

Autori: Joakim Kofod Betina Elfving Elisabeth Handberg Nielsen a ďalší

Zdroj: Kofod, J, Elfving, B, Nielsen, E H, Mors, O & Köhler-Forsberg, O 2022, 'Depression and inflammation : Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis', European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, vol. 54, pp. 116-125. https://doi.org/10.1016/j.euroneuro.2021.09.006

Predmety: Adult, Male, Nortriptyline, Citalopram, Antidepressive Agents/therapeutic use, Psychoimmunology, 03 medical and health sciences, Escitalopram, 0302 clinical medicine, Depression/drug therapy, Recurrence, Inflammation/drug therapy, Humans, Citalopram/therapeutic use, Inflammation, Depressive Disorder, Major, Depressive Disorder, Major/drug therapy, Depression, Prognosis, Personalized medicine, Antidepressive Agents, 3. Good health, Treatment Outcome, Cytokines, Female, Anti-inflammatory, Biomarkers

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34598835
https://europepmc.org/article/MED/34598835
https://www.sciencedirect.com/science/article/pii/S0924977X21007562
https://pure.au.dk/portal/en/publications/bcacf50a-e512-4abd-802f-2e3a2e60bac0
https://pure.au.dk/portal/en/publications/bcacf50a-e512-4abd-802f-2e3a2e60bac0
https://pure.au.dk/ws/files/352590074/1-s2.0-S0924977X21007562-main.pdf
https://doi.org/10.1016/j.euroneuro.2021.09.006

Healthcare use for major depressive disorders among middle-aged and older adults in the community

Autori: Nicolas Hoertel Frédéric Limosin Marie-Pierre F. Strippoli a ďalší

Zdroj: Social psychiatry and psychiatric epidemiology, vol. 57, no. 5, pp. 953-961

Predmety: Aged, Aged, 80 and over, Antidepressive Agents/therapeutic use, Delivery of Health Care, Depressive Disorder, Major/diagnosis, Depressive Disorder, Major/drug therapy, Depressive Disorder, Major/epidemiology, Humans, Middle Aged, Prospective Studies, Psychotropic Drugs/therapeutic use, Antidepressant, Depression, Healthcare use, Old-age psychiatry, Population-based study, PsyCoLaus, Depressive Disorder, Major, Psychotropic Drugs, 03 medical and health sciences, 0302 clinical medicine, Antidepressive Agents, 3. Good health

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34842964
https://link.springer.com/article/10.1007/s00127-021-02193-8
https://www.ncbi.nlm.nih.gov/pubmed/34842964
https://serval.unil.ch/resource/serval:BIB_FFE5E50D3497.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_FFE5E50D34976
https://serval.unil.ch/notice/serval:BIB_FFE5E50D3497

Antidepressant use in low- middle- and high-income countries: a World Mental Health Surveys report: A World Mental Health Surveys report

Autori: Kazdin, Alan E. Wu, Chi Shin Hwang, Irving a ďalší

Zdroj: PSYCHOLOGICAL MEDICINE
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Kazdin, A E, Wu, C S, Hwang, I, Puac-Polanco, V, Sampson, N A, Al-Hamzawi, A, Alonso, J, Andrade, L H, Benjet, C, Caldas-De-Almeida, J M, De Girolamo, G, De Jonge, P, Florescu, S, Gureje, O, Haro, J M, Harris, M G, Karam, E G, Karam, G, Kovess-Masfety, V, Lee, S, McGrath, J J, Navarro-Mateu, F, Nishi, D, Oladeji, B D, Posada-Villa, J, Stein, D J, Üstün, T B, Vigo, D V, Zarkov, Z, Zaslavsky, A M, Kessler, R C & the WHO World Mental Health Survey Collaborators 2023, 'Antidepressant use in low-middle-and high-income countries : A World Mental Health Surveys report', Psychological Medicine, vol. 53, no. 4, pp. 1583-1591. https://doi.org/10.1017/S0033291721003160

Predmety: Depressive Disorder, Major, perceived effectiveness, Depressive Disorder, Major/drug therapy, Developed Countries, reasons for use, Antidepressant medications, Antidepressive Agents/therapeutic use, Health Surveys, Antidepressive Agents, 3. Good health, Perceived effectiveness, 03 medical and health sciences, 0302 clinical medicine, Reasons for use, Surveys and Questionnaires, Humans, Developing Countries

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37010212
http://doi.org/10.1017/S0033291721003160
http://hdl.handle.net/10230/59589
https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=23109
https://novaresearch.unl.pt/en/publications/antidepressant-use-in-low-middle-and-high-income-countries-a-worl
https://espace.library.uq.edu.au/view/UQ:cef1919

Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study

Autori: Philipp Ritter Vera M Ludwig Michael Bauer a ďalší

Zdroj: CNS Drugs

Predmety: Adult, Male, Neurology, Antidepressive Agents/adverse effects [MeSH], Aged [MeSH], Ketamine/pharmacology [MeSH], Tranylcypromine/pharmacology [MeSH], Depressive Disorder, Major/drug therapy [MeSH], Psychopharmacology, Cohort Studies [MeSH], Ketamine/administration, Male [MeSH], Heart Rate/drug effects [MeSH], Drug Interactions [MeSH], Original Research Article, Monoamine Oxidase Inhibitors/administration, Tranylcypromine/administration, Pharmacotherapy, Tranylcypromine/adverse effects [MeSH], Dose-Response Relationship, Drug [MeSH], Antidepressive Agents/administration, Female [MeSH], Adult [MeSH], Humans [MeSH], Blood Pressure/drug effects [MeSH], Monoamine Oxidase Inhibitors/pharmacology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Depressive Disorder, Treatment-Resistant/drug therapy [MeSH], Administration, Intravenous [MeSH], Injections, Subcutaneous [MeSH], Monoamine Oxidase Inhibitors/adverse effects [MeSH], Psychiatry, Young Adult [MeSH], Ketamine/adverse effects [MeSH], Neurosciences, Antidepressive Agents/pharmacology [MeSH], Monoamine Oxidase Inhibitors, Injections, Subcutaneous, Blood Pressure, Cohort Studies, Depressive Disorder, Treatment-Resistant, 03 medical and health sciences, 0302 clinical medicine, Heart Rate, Humans, Drug Interactions, Aged, Retrospective Studies, Depressive Disorder, Major, Dose-Response Relationship, Drug, Middle Aged, Antidepressive Agents, 3. Good health, Administration, Intravenous, Female, Ketamine, Tranylcypromine

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s40263-021-00837-6.pdf
https://pubmed.ncbi.nlm.nih.gov/34283390
https://www.ncbi.nlm.nih.gov/pubmed/34283390
https://link.springer.com/content/pdf/10.1007/s40263-021-00837-6.pdf
https://pubmed.ncbi.nlm.nih.gov/34283390/
https://link.springer.com/article/10.1007/s40263-021-00837-6
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354966
https://repository.publisso.de/resource/frl:6464961

Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017

Autori: Johanna Seifert Fabienne Führmann Matthias A. Reinhard a ďalší

Zdroj: J Neural Transm (Vienna)

Predmety: Male, 2. Zero hunger, Depressive Disorder, Major, Sex Characteristics, Psychiatry and Preclinical Psychiatric Studies - Original Article, Antidepressive Agents, 3. Good health, Pharmacovigilance, 03 medical and health sciences, Antidepressive Agents/adverse effects [MeSH], Female [MeSH], Pharmacovigilance [MeSH], Antidepressant drugs, Antipsychotic Agents/therapeutic use [MeSH], Humans [MeSH], Depressive Disorder, Major/drug therapy [MeSH], Drug safety, Gender, Depressive Disorder, Major/epidemiology [MeSH], Depression, Male [MeSH], Psychopharmacotherapy, Sex Characteristics [MeSH], Antipsychotic drugs, 0302 clinical medicine, Humans, Female, 10. No inequality, Antipsychotic Agents

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00702-021-02349-5.pdf
https://pubmed.ncbi.nlm.nih.gov/33977402
https://link.springer.com/content/pdf/10.1007/s00702-021-02349-5.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205885
https://europepmc.org/article/PMC/PMC8205885
https://www.ncbi.nlm.nih.gov/pubmed/33977402
https://link.springer.com/article/10.1007/s00702-021-02349-5
https://repository.publisso.de/resource/frl:6446552

Esketamine in Treatment Resistant Depression: The Way to Remission

Autori: Bruno Prates Rui Neves Daniel Esteves-Sousa a ďalší

Zdroj: Revista Portuguesa de Psiquiatria e Saúde Mental, Vol 7, Iss 1 (2021)

Predmety: Psychiatry, Depressive Disorder, Major/drug therapy, Depressive Disorder, Treatment‑Resistant/ drug therapy, Esketamine/administration & dosage, RC435-571, Psychology, Antidepressive Agents, BF1-990, 3. Good health

Prístupová URL adresa: https://www.revistapsiquiatria.pt/index.php/sppsm/article/download/174/76
https://doaj.org/article/2e7701640f5f4e458463715a9dfb434e
https://www.revistapsiquiatria.pt/index.php/sppsm/user/setLocale/pt_PT?source=%2Findex.php%2Fsppsm%2Farticle%2Fview%2F174

Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram

Autori: Marina Šagud Nela Pivac Anja Dvojkovic a ďalší

Zdroj: Psychopharmacology. 238:1575-1584

Predmety: cognition, MDD, Adult, Male, vortioxetine, escitalopram, memory, executivefunction, BDNF, depression, Adolescent, Depressive Disorder, Major / drug therapy, Memory, Short-Term / drug effects, Brain-Derived Neurotrophic Factor / blood, Citalopram, Young Adult, 03 medical and health sciences, Cognition, 0302 clinical medicine, Citalopram / therapeutic use, Vortioxetine / therapeutic use, Humans, Cognitive Dysfunction, Aged, Antidepressive Agents / therapeutic use, Cognitive Dysfunction / drug therapy, Depressive Disorder, Major, Brain-Derived Neurotrophic Factor, Middle Aged, Antidepressive Agents, 3. Good health, Memory, Short-Term, Cognition / drug effects, Female, Vortioxetine

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/33560444
https://www.bib.irb.hr/1110641
https://doi.org/10.1007/s00213-021-05790-2
https://link.springer.com/article/10.1007/s00213-021-05790-2
https://doi.org/10.1007/s00213-021-05790-2
https://link.springer.com/article/10.1007/s00213-021-05790-2
https://pubmed.ncbi.nlm.nih.gov/33560444/
https://europepmc.org/article/MED/33560444
https://repozitorij.mef.unizg.hr/islandora/object/mef%3A3755
https://www.bib.irb.hr/1110641
https://www.ncbi.nlm.nih.gov/pubmed/33560444
https://urn.nsk.hr/urn:nbn:hr:105:069589
https://doi.org/10.1007/s00213-021-05790-2

Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity

Autori: Tanja Richter-Schmidinger Christiane Mühle Bernd Lenz a ďalší

Zdroj: J Neural Transm (Vienna)

Predmety: 2. Zero hunger, Depressive Disorder, Major, Hypothalamo-Hypophyseal System, Hydrocortisone, Depression, Psychiatry and Preclinical Psychiatric Studies - Original Article, Pituitary-Adrenal System, Dexamethasone, Interleukin-10, 3. Good health, 03 medical and health sciences, Receptors, Glucocorticoid, 0302 clinical medicine, Hypothalamic–pituitary–adrenal axis, Humans [MeSH], Depressive Disorder, Major/drug therapy [MeSH], Interleukin-10 [MeSH], Dexamethasone [MeSH], Receptors, Glucocorticoid/metabolism [MeSH], Depression [MeSH], Cytokines, Glucocorticoid receptor, Pituitary-Adrenal System [MeSH], Hydrocortisone [MeSH], Hypothalamo-Hypophyseal System/metabolism [MeSH], Humans, ddc:610

Popis súboru: application/pdf

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00702-020-02288-7.pdf
https://pubmed.ncbi.nlm.nih.gov/33447872
https://link.springer.com/article/10.1007/s00702-020-02288-7
https://europepmc.org/article/PMC/PMC7815576
https://pubmed.ncbi.nlm.nih.gov/33447872/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815576
https://link.springer.com/content/pdf/10.1007/s00702-020-02288-7.pdf
https://opus4.kobv.de/opus4-fau/files/22224/s00702-020-02288-7.pdf
https://repository.publisso.de/resource/frl:6446580

Concomitant lorazepam use and antidepressive efficacy of repetitive transcranial magnetic stimulation in a naturalistic setting

Autori: Mohamed A. Abdelnaim Tobias Hebel Peter M. Kreuzer a ďalší

Zdroj: Eur Arch Psychiatry Clin Neurosci
European archives of psychiatry and clinical neuroscience 271(1), 61-67 (2021). doi:10.1007/s00406-020-01160-9

Predmety: Male, Original Paper, Depressive Disorder, Major, Depression, Lorazepam, Female [MeSH], Depressive Disorder, Major/therapy [MeSH], Transcranial Magnetic Stimulation [MeSH], Humans [MeSH], Depressive Disorder, Major/drug therapy [MeSH], Treatment Outcome [MeSH], rTMS, Lorazepam/administration, Retrospective Studies [MeSH], Middle Aged [MeSH], Affective disorder, Brain stimulation, Male [MeSH], Depression/therapy [MeSH], Lorazepam/therapeutic use [MeSH], Benzodiazepine, Depression/drug therapy [MeSH], Middle Aged, Transcranial Magnetic Stimulation, 3. Good health, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Humans, Female, 10. No inequality, Retrospective Studies

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00406-020-01160-9.pdf
https://pubmed.ncbi.nlm.nih.gov/32648109
https://link.springer.com/content/pdf/10.1007/s00406-020-01160-9.pdf
https://pubmed.ncbi.nlm.nih.gov/32648109/
https://europepmc.org/article/PMC/PMC7867521
https://link.springer.com/article/10.1007/s00406-020-01160-9
https://epub.uni-regensburg.de/44851/
https://www.ncbi.nlm.nih.gov/pubmed/32648109
https://repository.publisso.de/resource/frl:6469550
https://publications.rwth-aachen.de/record/846545